Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia

The modest successes of targeted therapies along with the curative effects of allogeneic hematopoietic stem cell transplantation (alloHSCT) in acute myeloid leukemia (AML) stimulate the development of new immunotherapies. One of the promising methods of immunotherapy is the activation of immune resp...

Descripción completa

Detalles Bibliográficos
Autor principal: Giannopoulos, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406869/
https://www.ncbi.nlm.nih.gov/pubmed/30759726
http://dx.doi.org/10.3390/jcm8020236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406869/
https://www.ncbi.nlm.nih.gov/pubmed/30759726
http://dx.doi.org/10.3390/jcm8020236

Ejemplares similares